Russell D Hull, MBBS, MSc
University of Calgary
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John F Tisdale, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Yasser Yehia El-Sayed
Stanford University
Shared therapeutic areas:
Vicente Alberola, MD
Hospital Arnau de Vilanova de Valencia
Shared therapeutic areas:
Carlos Bosh Roig, MD
Hospital Universitario Doctor Peset
Shared therapeutic areas:
César Rodríguez Sánchez, MD
Hospital Clínico de Salamanca
Shared therapeutic areas:
Csaba Bela Szekely, MD
Arad District Hospital
Shared therapeutic areas:
Danielle Armas, MD
Celerion
Shared therapeutic areas:
Yongjun Wang, MD
Beijing Tiantan Hospital
Shared therapeutic areas:
Vicente Vicente, MD
Hospital Morales Meseguer
Shared therapeutic areas:
José Mateo, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
All 2 trials loaded